so.cardoso
TL2 Moderator · Chennai
Contributes reviews on supplier material. Based in Chennai.
Joined 11 September 2024 · last posted 2d
80 posts, newest first. Showing up to 150.
-
Journal club: what we got wrong in an earlier session Replied, post #123 · Evidence › Journal club · 26 Jul 2026 · 0 likes Coming back to post #121, because the follow-up matters more than the original answer. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using…
-
What is genuinely unknown about long-term amylin agonism Replied, post #67 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2026 · 14 likes post #66 answers the question as asked. The question underneath it is different. Historical amylin analogues: pramlintide was the only long-acting amylin analogue…
-
Reading a home test result without over-claiming Replied, post #126 · Analytics › Home & field testing · 19 Jul 2026 · 4 likes Worth separating two things that post #122 runs together. Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result…
-
Revisiting: The best-written scientific paper you have read Replied, post #95 · Lounge › Off topic · 16 Jul 2026 · 14 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #52 · Practice › Side effects · 15 Jul 2026 · 8 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #26 · Compounds › Repair & healing peptides · 12 Jul 2026 · 25 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
A structured critique template this community uses — a second dataset Replied, post #33 · Evidence › Study critique · 9 Jul 2026 · 24 likes Worth separating two things that post #29 runs together. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes…
-
Second pass at: Reading a trial's population section before its results Replied, post #3 · marked as the solution · Evidence › Trials · 9 Jul 2026 · 12 likes Coming back to the opening post, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic…
-
Pooling trials with different estimands Replied, post #81 · Evidence › Meta-analyses · 8 Jul 2026 · 3 likes This follows post #78 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Insurance and replacement policies, compared Replied, post #58 · Sourcing › Logistics · 2 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #40 · Compounds › Tirzepatide · 16 Jun 2026 · 0 likes Coming back to post #38, because the follow-up matters more than the original answer. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #87 · Evidence › Journal club · 15 Jun 2026 · 11 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Coming back to: Time to steady state after a dose increase Replied, post #75 · Pharmacology › Pharmacokinetics · 12 Jun 2026 · 24 likes This follows post #72 rather than contradicting it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the…
-
Micronutrient adequacy at low total intake Replied, post #56 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 5 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #53 · Analytics › HPLC & UHPLC · 5 Jun 2026 · 26 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
-
Prescription portability between countries Replied, post #49 · Access › International · 31 May 2026 · 8 likes Worth separating two things that post #45 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Revisiting: What pooling buys you and what it destroys Replied, post #36 · Evidence › Meta-analyses · 28 May 2026 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Validating a calculator against hand arithmetic Replied, post #21 · Data & Tools › Calculators · 28 Apr 2026 · 18 likes Worth separating two things that post #17 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
List price versus negotiated price versus what you pay Replied, post #50 · Access › Pricing · 12 Apr 2026 · 0 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
-
Spike-and-recover accuracy for a peptide assay Replied, post #39 · Analytics › Method validation · 8 Apr 2026 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A plateau that disappeared when I changed how I measured Replied, post #30 · Outcomes › Progress reports · 7 Apr 2026 · 12 likes I read post #28 twice before replying, because I had assumed the opposite. Measurement noise: day-to-day body mass varies by more than a kilogram on hydration,…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #5 · Pharmacology › Pharmacokinetics · 3 Apr 2026 · 0 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Second pass at: Identical chromatograms across two different lots Replied, post #92 · Sourcing › Red flags · 25 Mar 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #146 · Access › International · 5 Mar 2026 · 0 likes post #145 answers the question as asked. The question underneath it is different. Regulatory position dates: a regulatory position is only current as of when it was…
-
Research-use-only labelling: what it means and what it does not Replied, post #94 · Sourcing › Regulatory · 28 Jan 2026 · 29 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #34 · Practice › Reconstitution · 28 Jan 2026 · 0 likes I read post #32 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #110 · Clinical › Special populations · 26 Jan 2026 · 0 likes Worth separating two things that post #106 runs together. Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #18 · Data & Tools › Datasets · 24 Jan 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #19 · Clinical › Special populations · 20 Jan 2026 · 7 likes I read post #17 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Request: a diff view for wiki revisions — the long version Replied, post #97 · Meta › Feature requests · 10 Jan 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Lyophilisation and why the cake looks the way it does Replied, post #27 · Pharmacology › Formulation chemistry · 29 Nov 2025 · 6 likes Lyophilisation and reconstitution: the powder is stable for extended periods if kept cool and dry. Once reconstituted, stability decreases because the dissolved peptide…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #88 · Compounds › Other compounds · 26 Nov 2025 · 3 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Availability by country, dated, with primary sources — one year on Replied, post #2 · Access › International · 25 Nov 2025 · 24 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Reading an interaction checker output critically Replied, post #49 · Practice › Interactions · 22 Nov 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The headache that turns out to be dehydration Replied, post #52 · Nutrition & Training › Hydration & electrolytes · 10 Nov 2025 · 19 likes Worth separating two things that post #48 runs together. Water intoxication: drinking excessive water (more than a few liters per day for extended time) without…
-
New subcategory: rationale and scope Replied, post #123 · Meta › Announcements · 26 Oct 2025 · 1 like Coming back to post #121, because the follow-up matters more than the original answer. RSS: if you prefer to receive announcements by feed rather than visiting the…
-
Run-in periods and the population they select Replied, post #13 · Evidence › Trials · 23 Oct 2025 · 21 likes I read post #11 twice before replying, because I had assumed the opposite. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a…
-
How to ask about something you suspect is a bad idea Replied, post #14 · Start Here › How to Ask · 6 Oct 2025 · 30 likes On post #10 — agreed on the reasoning, with one qualification. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #93 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #87 · Evidence › Preprints · 2 Oct 2025 · 31 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #32 · Compounds › Tirzepatide · 30 Sep 2025 · 24 likes This follows post #29 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Adolescents: a distinct evidence base — one year on Replied, post #20 · Clinical › Special populations · 28 Sep 2025 · 5 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Second pass at: Programming during a large energy deficit Replied, post #13 · Nutrition & Training › Resistance training · 20 Sep 2025 · 3 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
Documentation that materially improves an appeal's chances Replied, post #3 · Access › Insurance & coverage · 15 Sep 2025 · 2 likes On the opening post — agreed on the reasoning, with one qualification. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2…
-
Washout: how long is long enough, and for what purpose Replied, post #65 · Pharmacology › Pharmacokinetics · 11 Sep 2025 · 0 likes Coming back to post #63, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Substitution between formats during a shortage Replied, post #45 · Access › Shortages · 26 Aug 2025 · 31 likes This follows post #42 rather than contradicting it. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #42 · Start Here › How to Ask · 22 Aug 2025 · 1 like Coming back to post #40, because the follow-up matters more than the original answer. Questions you cannot explain: "I cannot say why I am asking this, but is this…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #29 · Start Here › Welcome · 22 Aug 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #12 · Clinical › Special populations · 21 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Temperature loggers worth the money — the long version Replied, post #23 · Devices › Cold chain · 11 Aug 2025 · 1 like Picking up post #20: that is the part I would want checked first. Assessing an excursion: if a package sat at room temperature for a time, visual inspection…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #32 · Analytics › HPLC & UHPLC · 10 Aug 2025 · 1 like Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #14 · Access › Pricing · 6 Aug 2025 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
What a documentation review can and cannot tell you Replied, post #59 · Sourcing › Independent verification · 3 Aug 2025 · 28 likes Coming back to post #57, because the follow-up matters more than the original answer. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #8 · Practice › Side effects · 28 Jul 2025 · 29 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Titles that describe the question, not the situation Replied, post #45 · Start Here › How to Ask · 10 Jul 2025 · 17 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #10 · Compounds › Semaglutide · 29 Jun 2025 · 2 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #125 · Access › Insurance & coverage · 15 Jun 2025 · 6 likes I read post #123 twice before replying, because I had assumed the opposite. Generic versus brand: most of these compounds do not have generic versions yet. Once they…
-
Price changes over 2025 and 2026, tabulated and dated Replied, post #9 · Access › Pricing · 12 Jun 2025 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #119 · Practice › Reconstitution · 29 May 2025 · 1 like The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #90 · Outcomes › Body composition · 24 May 2025 · 26 likes Coming back to post #88, because the follow-up matters more than the original answer. Resting metabolic rate: body composition affects metabolic rate. As fat mass…
-
Washout: how long is long enough, and for what purpose Replied, post #25 · Pharmacology › Pharmacokinetics · 10 May 2025 · 11 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
A claim built entirely on a subgroup analysis Replied, post #10 · Evidence › Study critique · 29 Apr 2025 · 13 likes post #9 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: What other technical communities get right that we do not Replied, post #50 · Lounge › Off topic · 27 Mar 2025 · 19 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
-
About the Journal club category Replied, post #7 · Evidence › Journal club · 24 Mar 2025 · 29 likes Picking up post #4: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #47 · Evidence › Journal club · 19 Mar 2025 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Adjudicated events and why the definition matters — the long version Replied, post #55 · Evidence › Trials · 19 Mar 2025 · 22 likes post #54 is right about the mechanism and I think understates the practical bit. Population narrowness: most trials in this class enrolled fairly specific groups.…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #41 · Devices › Syringes & needles · 13 Mar 2025 · 3 likes post #40 is right about the mechanism and I think understates the practical bit. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead…
-
Coming back to: Why the cheapest option is often not the cheapest Replied, post #13 · Access › Pricing · 11 Mar 2025 · 25 likes Worth separating two things that post #9 runs together. Subscription services and subscriptions: some online clinics bundle compounds into subscription models with…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #57 · Compounds › Secretagogues & GH axis · 29 Jan 2025 · 2 likes I read post #55 twice before replying, because I had assumed the opposite. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms.…
-
Fixed versus detachable needles: the trade-offs Replied, post #86 · Devices › Syringes & needles · 2 Jan 2025 · 22 likes Worth separating two things that post #82 runs together. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #52 · Compounds › Other compounds · 30 Dec 2024 · 0 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #29 · Compounds › Semaglutide · 20 Dec 2024 · 3 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #4 · Access › Pricing · 15 Dec 2024 · 0 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Promotion criteria, and the one that stops most nominations Replied, post #135 · Documentation › Doc review · 8 Dec 2024 · 0 likes Citation checking: if a maintained page cites a paper, the citation should match what the paper actually says. If you notice a mismatch, post it here.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #25 · Compounds › Secretagogues & GH axis · 28 Nov 2024 · 1 like Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #6 · Evidence › Preprints · 19 Nov 2024 · 0 likes post #5 answers the question as asked. The question underneath it is different. What changes between preprint and publication: authors respond to reviewer comments,…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #117 · Clinical › Comorbidities · 28 Oct 2024 · 18 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Converting between mg/mL and units per dose, both directions Replied, post #17 · Practice › Reconstitution · 11 Sep 2024 · 8 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Air bubbles in a subcutaneous injection: the honest risk assessment Replied, post #3 · Practice › Administration · 30 Aug 2024 · 8 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #75 · Compounds › Retatrutide · 21 Jul 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.